Clinical trials explained
In the UK, it takes over 12 years to develop a new medicine to the standards of quality, efficacy and safety laid down by legislation. It typically costs £1.15 billion to do all the research and development necessary before a new medicine can be licensed for use. The majority of medicines under development never make it to the market; following thorough studies, they may be found to have unacceptable side effects, or they don’t work any better than existing treatments. Timeline of medicine development For every marketed medicine that makes enough money to pay for its development, about 25,000 chemical compounds were tested, on average 25 of these will have gone into clinical trials and five received approval for marketing. Our timeline of medicine development shows the stages a…
MS News: February 2015
Time flies, as we’re once again nearing the end of February. It’s been an attention-grabbing month, with several positive news stories about treatment and also, about a rather interesting collaboration between Google and Biogen Idec. First of all though, I wanted to add a link displaying how many clinical trials are ongoing as we speak. So dig in, and feel a little bit happier knowing that each day, a lot of people are seeking and working towards better treatment. Additionally, I added two new categories to the list, news about MS Organisations and Diet also. Highlight! Data Visualization Displays 142 Ongoing MS Clinical Trials MURDOCK study confirms Google partnership Google, Biogen Seek Reasons for Advance of Multiple Sclerosis Google Inc (GOOG) And Biogen Idec Inc Join Hands For Multiple Sclerosis…
MS News: January 2015
The first month of 2015 has come and (almost) gone again. With that, it’s full steam ahead in the field of MS research, clinical trials, business news and interesting, general newsworthy bits and pieces. This month, the highlight was the news about MS and stem cell treatment, providing a decent outlook for those looking for alternative treatment. I’ll keep following this news throughout the year, and in the meantime, check out the Highlight! section where the news was published, with usual news stories further down this web page.
MS News: December 2014
Well, it was a busy December, in more ways than one. I hope you all had a great Christmas and wish you the best for 2015. From the amount of research and clinical news we keep hearing about month after month, I can only be optimistic for the future. A cure will not happen tomorrow, next year or even in five years, but we’re edging closer to more relief. My wish is that all those people with primary and secondary MS will receive better treatment options than they now have.
MS News: November 2014 (*F)
"Hoping for a cure? Of course. I am realistic though, as it might not happen in my lifetime. Simply being part of the solution, is all I wish for right now. Whichever comes first, the 8,000 people with MS in Ireland, 100,000 in the UK, 400,000 in the US and many other people around the world are looking forward, and simply... hope."
MS News: October 2014
“54 New MS Research Projects to Receive Millions of Dollars in Funding.” I can only jump up and down like a child at Christmas reading about this. Even if or when we’re struggling with our illness, we know that lots is happening to help us forward in life. So please, enjoy the list with research & clinical trial news, updates on current medication and business & general news."
MS News: September 2014
It has been a big and very busy September for researchers, clinical trials and pharmaceutical companies. Early this month, the Joint ACTRIMS/ECTRIMS Meeting took place in Boston. For more, please check the extensive website of the conference.